These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34280031)

  • 21. Hypoglycemic and hypolipidemic effects of Epigynum auritum in high fat diet and streptozotocin-induced diabetic rats.
    Yang ML; Lu C; Fan ZF; Zhao TR; Cheng GG; Wang YD; Cao JX; Liu YP
    J Ethnopharmacol; 2022 Apr; 288():114986. PubMed ID: 35032587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated 16S rRNA Sequencing and Untargeted Metabolomics Analysis to Reveal the Protective Mechanisms of
    Zhang H; Li H; Pan B; Zhang S; Su X; Sun W; Zhang T; Zhang Z; Lv S; Cui H
    Curr Drug Metab; 2023; 24(4):270-282. PubMed ID: 37038712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidiabetic effects of Morus alba fruit polysaccharides on high-fat diet- and streptozotocin-induced type 2 diabetes in rats.
    Jiao Y; Wang X; Jiang X; Kong F; Wang S; Yan C
    J Ethnopharmacol; 2017 Mar; 199():119-127. PubMed ID: 28163112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-hyperglycemic and anti-hyperlipidemic effects of a special fraction of Luohanguo extract on obese T2DM rats.
    Zhang Y; Zhou G; Peng Y; Wang M; Li X
    J Ethnopharmacol; 2020 Jan; 247():112273. PubMed ID: 31586692
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Park JE; Oh SH; Cha YS
    Nutrients; 2020 Feb; 12(3):. PubMed ID: 32110872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-diabetic effects of shubat in type 2 diabetic rats induced by combination of high-glucose-fat diet and low-dose streptozotocin.
    Manaer T; Yu L; Zhang Y; Xiao XJ; Nabi XH
    J Ethnopharmacol; 2015 Jul; 169():269-74. PubMed ID: 25922265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Inonotus obliquus (Fr.) Pilat extract on the regulation of glycolipid metabolism via PI3K/Akt and AMPK/ACC pathways in mice.
    Zhang Z; Liang X; Tong L; Lv Y; Yi H; Gong P; Tian X; Cui Q; Liu T; Zhang L
    J Ethnopharmacol; 2021 Jun; 273():113963. PubMed ID: 33640441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects.
    Wang X; Liu R; Zhang W; Zhang X; Liao N; Wang Z; Li W; Qin X; Hai C
    Mol Cell Endocrinol; 2013 Aug; 376(1-2):70-80. PubMed ID: 23791844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quamoclit angulata extract supplementation attenuates hepatic damage via regulation of AMPK/SIRT associated hepatic lipid metabolism in streptozotocin and high fat diet-induced T2DM mice.
    Lee H; Kim Y; Kim SY; Lim Y
    Nutr Res; 2022 Aug; 104():10-19. PubMed ID: 35533425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive in silico analysis of the probiotics, and preparation of compound probiotics-Polygonatum sibiricum saponin with hypoglycemic properties.
    Luo J; Jiang L; Gao B; Chai Y; Bao Y
    Food Chem; 2023 Mar; 404(Pt A):134569. PubMed ID: 36244070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CTRP1 prevents high fat diet-induced obesity and improves glucose homeostasis in obese and STZ-induced diabetic mice.
    Ren M; Pan J; Yu X; Chang K; Yuan X; Zhang C
    J Transl Med; 2022 Oct; 20(1):449. PubMed ID: 36195912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A refined-JinQi-JiangTang tablet ameliorates prediabetes by reducing insulin resistance and improving beta cell function in mice.
    Gao LH; Liu Q; Liu SN; Chen ZY; Li CN; Lei L; Sun SJ; Li LY; Liu JL; Shen ZF
    J Ethnopharmacol; 2014; 151(1):675-85. PubMed ID: 24286962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice.
    Gupta AP; Garg R; Singh P; Goand UK; Syed AA; Valicherla GR; Riyazuddin M; Mugale MN; Gayen JR
    Eur J Pharmacol; 2020 Aug; 881():173204. PubMed ID: 32439261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lactoferrin improves hepatic insulin resistance and pancreatic dysfunction in high-fat diet and streptozotocin-induced diabetic mice.
    Du Y; Li D; Chen J; Li YH; Zhang Z; Hidayat K; Wan Z; Xu JY; Qin LQ
    Nutr Res; 2022 Jul; 103():47-58. PubMed ID: 35477124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoglycemic, hypolipidemic and antioxidant effects of Sarcandra glabra polysaccharide in type 2 diabetic mice.
    Liu W; Zheng Y; Zhang Z; Yao W; Gao X
    Food Funct; 2014 Nov; 5(11):2850-60. PubMed ID: 25254968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced hypoglycemic effects of konjac glucomannan combined with Polygonatum cyrtonema Hua polysaccharide in complete nutritional liquid diet fed type 2 diabetes mice.
    Chang L; Goff HD; Ding C; Liu Q; Zhao S; Tao T; Lu R; Gao Y; Wu H; Guo L
    Int J Biol Macromol; 2024 May; 266(Pt 1):131121. PubMed ID: 38522692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoglycemic effect of deoxynojirimycin-polysaccharide on high fat diet and streptozotocin-induced diabetic mice via regulation of hepatic glucose metabolism.
    Li YG; Ji DF; Zhong S; Lin TB; Lv ZQ
    Chem Biol Interact; 2015 Jan; 225():70-9. PubMed ID: 25446853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidiabetic effect of total flavonoids from Sanguis draxonis in type 2 diabetic rats.
    Chen F; Xiong H; Wang J; Ding X; Shu G; Mei Z
    J Ethnopharmacol; 2013 Oct; 149(3):729-36. PubMed ID: 23933499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rutaecarpine exhibits anti-diabetic potential in high fat diet-multiple low dose streptozotocin induced type 2 diabetic mice and in vitro by modulating hepatic glucose homeostasis.
    Surbala L; Singh CB; Devi RV; Singh OJ
    J Pharmacol Sci; 2020 Aug; 143(4):307-314. PubMed ID: 32536591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.